| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000154.txt","as_of":"2026-04-03T11:12:58.166696+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000154.txt","company":"VERTEX PHARMACEUTICALS INC / MA","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000154.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_6e3ffa05746cfcd4","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000154.txt","content_type":"text/plain","enriched_at":"2026-04-03T13:52:16.050121+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"Document","final_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000154.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000154.txt","source_event_id":"evt_46a90768d7cf","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"129a8c57f15b07ba","kind":"sec_filing","published_at":"20260402","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":1.0,"dates_mentioned":["2026-04-02"],"entities":[{"asset_class":"equity","name":"Vertex Pharmaceuticals Inc","relevance":"high","symbol":"VRTX","type":"company"}],"event_type":"listing","information_gaps":["No specific material items disclosed in the filing."],"key_facts":["Filing date: April 2, 2026","Form type: DEFA14A","Company: Vertex Pharmaceuticals Inc","State of incorporation: MA","Business address: 50 Northern Avenue, Boston, MA 02210"],"numeric_claims":[],"primary_claim":"Vertex Pharmaceuticals filed a DEFA14A form on April 2, 2026.","relevance_score":0.8,"sentiment":"neutral","source_quality":"high","summary":"Vertex Pharmaceuticals filed a DEFA14A form with the SEC, indicating definitive additional materials related to a proxy statement.","topics":["SEC Filing","Proxy Statement"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 VERTEX PHARMACEUTICALS INC / MA \u00b7 Filed 20260402","ticker":"VRTX","tickers":["VRTX"],"title":"VRTX filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000154.txt"}... |